Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9

NCT00000344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Opioid-Related Disorders

Interventions

DRUG: Buprenorphine/naloxone

Sponsor

National Institute on Drug Abuse (NIDA)